Defeating Alzheimer's disease and other dementias: a priority for European science and society
Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …
Amsterdam dementia cohort: performing research to optimize care
WM Van Der Flier, P Scheltens - Journal of Alzheimer's …, 2018 - content.iospress.com
The Alzheimer center of the VU University Medical Center opened in 2000 and was initiated
to combine both patient care and research. Together, to date, all patients forming the …
to combine both patient care and research. Together, to date, all patients forming the …
Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial
E Teng, PT Manser, K Pickthorn, F Brunstein… - JAMA …, 2022 - jamanetwork.com
Importance Neurofibrillary tangles composed of aggregated tau protein are one of the
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease …
neuropathological hallmarks of Alzheimer disease (AD) and correlate with clinical disease …
Optimizing patient care and research: the Amsterdam Dementia Cohort
WM van der Flier, YAL Pijnenburg… - Journal of …, 2014 - content.iospress.com
Since its opening in 2000, patient care and research go hand in hand at the Alzheimer
center of the VU University Medical Center, both organized in such a way that they mutually …
center of the VU University Medical Center, both organized in such a way that they mutually …
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Background Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …
progression in preclinical Alzheimer's disease. We assessed associations between brain β …
Computerized cognitive testing for older adults: a review
S Zygouris, M Tsolaki - American Journal of Alzheimer's …, 2015 - journals.sagepub.com
Objective: This article is a review of computerized tests and batteries used in the cognitive
assessment of older adults. Method: A literature search on Medline followed by cross …
assessment of older adults. Method: A literature search on Medline followed by cross …
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease
SS Assunção, RA Sperling, C Ritchie… - Alzheimer's research & …, 2022 - Springer
Background The need for preventive therapies that interrupt the progression of Alzheimer's
disease (AD) before the onset of symptoms or when symptoms are emerging is urgent and …
disease (AD) before the onset of symptoms or when symptoms are emerging is urgent and …
[HTML][HTML] Measuring cognition and function in the preclinical stage of Alzheimer's disease
S Weintraub, MC Carrillo, ST Farias… - Alzheimer's & Dementia …, 2018 - Elsevier
Abstract The Alzheimer's Association's Research Roundtable met in November 2016 to
explore how best to measure changes in cognition and function in the preclinical stage of …
explore how best to measure changes in cognition and function in the preclinical stage of …
European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS): study protocol
A Solomon, M Kivipelto, JL Molinuevo, B Tom… - BMJ open, 2018 - bmjopen.bmj.com
Introduction The European Prevention of Alzheimer's Dementia (EPAD) project is funded
initially by the Innovative Medicines Initiative and has been established to overcome the …
initially by the Innovative Medicines Initiative and has been established to overcome the …
[HTML][HTML] Detecting functional decline from normal aging to dementia: development and validation of a short version of the Amsterdam IADL Questionnaire
RJ Jutten, CFW Peeters, SMJ Leijdesdorff… - Alzheimer's & Dementia …, 2017 - Elsevier
Introduction Detecting functional decline from normal aging to dementia is relevant for
diagnostic and prognostic purposes. Therefore, the Amsterdam IADL Questionnaire (A-IADL …
diagnostic and prognostic purposes. Therefore, the Amsterdam IADL Questionnaire (A-IADL …